Northcote R J, Ballantyne D
Br Med J (Clin Res Ed). 1986 Jul 12;293(6539):97-9. doi: 10.1136/bmj.293.6539.97.
The long term effect of beta blockers and the influence of intrinsic sympathomimetic activity on respiratory function were assessed in patients with chronic stable angina pectoris randomised to receive treatment with propranolol (n = 21) or pindolol (n = 19) for one year. Forced expiratory volume in one second (FEV1) had fallen by a mean of 240 ml after one year (p less than 0.001) in those treated with propranolol compared with 120 ml in those treated with pindolol (p less than 0.05). The difference between the groups was significant (p less than 0.01). Vital capacity fell significantly only in those treated with propranolol (p less than 0.05 at one year). In those in whom the basal ratio of FEV1 to forced vital capacity was low (less than 70%) propranolol, but not pindolol, caused a significant (p less than 0.05) fall in FEV1 throughout treatment. Long term administration of pindolol has a less adverse effect on respiratory function than propranolol, which results in a progressive deterioration in respiratory function over one year.
在随机接受普萘洛尔(n = 21)或吲哚洛尔(n = 19)治疗一年的慢性稳定型心绞痛患者中,评估了β受体阻滞剂的长期效果以及内在拟交感活性对呼吸功能的影响。与接受吲哚洛尔治疗的患者下降120毫升(p<0.05)相比,接受普萘洛尔治疗的患者一秒用力呼气量(FEV1)在一年后平均下降了240毫升(p<0.001)。两组之间的差异具有显著性(p<0.01)。仅接受普萘洛尔治疗的患者肺活量显著下降(一年时p<0.05)。在FEV1与用力肺活量的基础比值较低(<70%)的患者中,在整个治疗过程中,普萘洛尔而非吲哚洛尔导致FEV1显著下降(p<0.05)。长期服用吲哚洛尔对呼吸功能的不良影响小于普萘洛尔,普萘洛尔会导致呼吸功能在一年中逐渐恶化。